The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. (Q53908001)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

title

The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

main subject

Helicobacter pylori

0 references

antibiotic resistance

1 reference

based on heuristic

inferred from title

author

Patrizia Zentilin

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

author name string

Savarino V

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Pivari M

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Bisso G

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Raffaella Mele M

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Bilardi C

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Borro P

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Dulbecco P

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Tessieri L

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Mansi C

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Borgonovo G

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

De Salvo L

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

Vigneri S

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

language of work or name

English

0 references

publication date

1 July 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

published in

Alimentary Pharmacology & Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

volume

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

page(s)

893-900

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

cites work

A new 1‐week therapy for Helicobacter pylori eradication: rani‐ tidine bismuth citrate plus two antibiotics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Antibiotic resistance in Helicobacter pylori: implications for therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Treatment of Helicobacter pylori Infection: A Review of the World Literature

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Eradication of Helicobacter pylori: an objective assessment of current therapies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Treating Helicobacter pylori--the best is yet to come?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

The Role of Ranitidine Bismuth Citrate in Significantly Reducing the Emergence of Helicobacter pylori Strains Resistant to Antibiotics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2036.2000.00780.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

PubMed publication ID

10886045

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10886045

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10886045

ResearchGate publication ID

12433160

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53908001&oldid=1240899301"